Response to 'The importance of immunosuppression as risk and prognostic factor for periorbital non-melanoma skin cancers'

Eye (Lond). 2018 Jan;32(1):160-161. doi: 10.1038/eye.2017.171. Epub 2017 Aug 25.

Authors

R C Gerring¹, C T Ott¹, J M Curry¹, Z B Sargi¹, S T Wester¹

Affiliation

¹ Division of Oculoplastic Surgery, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Basal Cell*
Humans
Prognosis
Risk Factors
Skin Neoplasms*